Fate Therapeutics Inc.

Professional, Scientific & Technical Services · Primarily CA · PERM filings 2022–2023

#16,000 top sponsor

Overview

Fate Therapeutics Inc. is a Professional, Scientific & Technical Services employer that has filed 4 PERM green-card applications between FY2022 and FY2023. That places it #16,000 among all U.S. PERM sponsors in our dataset. 3 were certified (75% approval rate), taking about 437 days on average. The most-sponsored role is Molecular and Cellular Biologists, with most worksites in CA, and the median sponsored wage is $100,000.

4

PERM filings

75%

approval

0

denied

$100,000

median wage

437d

avg processing

Worker background

Across 1 filings with beneficiary data, the most common country of origin is AUSTRALIA (100%). (From legacy PERM form data, FY2020–FY2024.)

Top countries of origin

  • Australia1

Prior visa status

  • E-31

Education

  • Doctorate1

PERM filings by year

Occupations & job titles

The occupations Fate Therapeutics Inc. most often sponsors, with average wages.

OccupationFilingsAvg wage
Molecular and Cellular Biologists 3 $100,000
Biochemists and Biophysicists 1 $106,600

Common job titles

Associate Scientist, Genomics 1 Scientist, Cancer Immunotherapy 1 Senior Research Associate, In Vivo Pharmacology 1 Associate Director, Cancer Immunotherapy 1

Worksite states

Wage range

$90,000

25th

$100,000

median

$106,600

75th

$110,000

90th

Law firms used

  • Fragomen, Del Rey, Bernsen & Loewy, LLP3
  • Fragomen, Del Rey, Bernsen Loewy, LLP1

Recent filings

CaseJob titleStatusWorksiteDecision
G-100-23317-498191 Scientist, Cancer ImmunotherapyCertified - Expired San Diego, CA Mar 31, 2025
G-100-23317-498220 Senior Research Associate, In Vivo PharmacologyCertified - Expired San Diego, CA Mar 31, 2025
G-100-23258-352496 Associate Scientist, GenomicsCertified - Expired San Diego, CA Jan 13, 2025
A-22034-06705 Associate Director, Cancer ImmunotherapyCertified - Expired San Diego, CA Nov 8, 2022

Source: U.S. DOL OFLC PERM disclosure data. Wages are annual-equivalent; outliers excluded.